COVID-19 - March 17, 2022
Nasal spray protecting from COVID-19 in Phase III trial
Researchers have developed a nasal spray to protect vulnerable people from not only COVID-19 but also from infection with several other viruses. The new treatment formulation that is being tested in a Phase 3 trial by the University of Cambridge in the United Kingdom. Morten Otto Alexander Sommer, one of the researchers behind the development […]
COVID-19 - March 16, 2022
Initiative supporting new antiviral medicines for future pandemics launched
The Novo Nordisk Foundation, Open Philanthropy, and the Bill & Melinda Gates Foundation have announced an initial commitment of up to 90 million USD of coordinated funding toward Pandemic Antiviral Discovery (PAD). PAD is a new initiative to catalyze discovery and early development of antiviral medicines for future pandemics. With equitable access as a core […]
COVID-19 - March 4, 2022
He is the Director of the new Health Emergency and Pandemic Science Center
Johan von Schreeb, Professor of global disaster medicine and Head of the Centre for Research on Health Care in Disasters at Karolinska Institutet, has been named Director of Karolinska Institutet’s (KI) newly established Health Emergency and Pandemic Science Center. The aim is to create a center based on KI’s knowledge and capability, that finds connections […]
COVID-19 - February 22, 2022
New insight into NK cells’ reaction to COVID-19
An international team of scientist led by researchers from Karolinska Institutet shows that natural killer (NK) cells respond to a certain peptide on the surface of infected cells. The study, published in Cell Reports, is an important piece of the puzzle in our understanding of how the immune system reacts to COVID-19, state the researchers. […]
COVID-19 - February 18, 2022
Oestrogen may protect against death in COVID-19
The female sex hormone oestrogen may have protective effect against becoming seriously ill and dying in COVID-19, according to a Umeå University study. “The results are interesting enough to warrant further clinical studies. However, it is absolutely inappropriate to start experimenting with supplements yourself because oestrogen can also cause a number of more or less […]
Clinical Trials - February 11, 2022
Vicore Pharma announces new data
Vicore Pharma has announced data from an interim analysis suggesting that C21 stabilizes disease and increases lung function in idiopathic pulmonary fibrosis (IPF) patients as quantified by standard FVC (Forced Vital Capacity) measurement. An interim analysis of the phase 2 proof-of-concept study in IPF (the AIR1study) showed an initial stabilization of disease and then an […]
